by Bob Shepard
Neurologist David Geldmacher, M.D., who leads the University of Alabama at Birmingham memory disorders program, sees a lot of older patients with memory loss, dementia or Alzheimer's disease.
One of the questions frequently asked of him by the caregivers of these patients, often a spouse or the patients' adult children, is "could this happen to me?"
"It is very common for family members of a patient receiving a diagnosis of Alzheimer's disease or other form of dementia to wonder about their own risk," said Geldmacher, the director of the UAB Division of Memory Disorders and Behavioral Neurology.
Geldmacher is launching a new clinical effort—the first of its type in the United States—to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age. The assessment will include family history, a detailed memory history for the patient, cognitive testing and a baseline MRI scan. That information can be incorporated into existing risk predictor models that have been validated by research studies to produce an accurate risk assessment.
Patients will get a comprehensive analysis from Geldmacher, including information on nonmodifiable risk factors such as age and family history, as well as strategies for dealing with modifiable risk factors like weight, diet, blood pressure and level of physical activity. He says research in the field has shown that reducing one or more risk factors can have a significant effect on reducing one's overall chances of developing Alzheimer's disease.
"Our goal is to understand what risk factors are present in each individual and create a plan that best helps them reduce their risk and make appropriate plans for the future," Geldmacher said.
The assessment is targeted primarily at individuals in their 50s and 60s, and it will provide a 20-year risk prediction. It can also be used for individuals in later life, with a six-year risk prediction.
"For most people, Alzheimer's disease is an illness you live with, not an illness from which you die," Geldmacher said. "With a better understanding of individual risk, there are steps that people can take to minimize the risk for serious memory loss."
Patients will have two clinical visits with Geldmacher and his staff. The first will be to compile histories and conduct testing. The second will be to review a personalized treatment plan, including how to access resources to help achieve lifestyle changes, and where to find supportive and educational materials. The clinic will also suggest coping strategies that can be employed to ease the burden of dementia on the individual and his or her family. The two-visit assessment is fee-for-service and will cost about $1,000, which includes the MRI scan.
Geldmacher says this risk assessment service appears to be the first in the nation offered in a clinical setting and not as part of a research study.
"It's really for those who are worried about their cognitive health but do not currently have major memory issues," he said. "People with active memory or cognitive issues that interfere with everyday activities are best cared for through the services of our existing UAB Memory Disorders Clinic."
Geldmacher anticipates that the risk assessment clinic will also ultimately serve as a gateway to research projects aimed at finding medications or other treatments designed to lower risk of memory disorders.
Explore further: Early cardiac risks linked to worse cognitive function in middle age
More information: http://ift.tt/1kqHQ6Y
Medical Xpress on facebook
Related Stories
Early cardiac risks linked to worse cognitive function in middle age
Mar 31, 2014
Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UC San Francisco.
Making sense of genetic testing for heart disease
Apr 28, 2014
(Medical Xpress)—A new study by academics at The University of Nottingham looks at how patients respond to genetic testing for risk of coronary heart disease (CHD).
Policy changes urgently needed as millions to start receiving early label of Alzheimer's
Apr 08, 2014
How will we, as individuals, and a society, live with brains at risk for Alzheimer's disease dementia? As part of Health Affairs' April issue, a theme issue focusing on Alzheimer's, a neurodegenerative disease ethicist and cl ...
New study announced that will use genetics to test for Alzheimer's risk
Jul 19, 2012
In a new Alzheimer's disease risk assessment study unveiled this week during the Alzheimer's Association International Conference, researchers at Brigham and Women's Hospital (BWH) are offering genetic testing and Alzheimer's ...
Physical activity keeps hippocampus healthy in people at risk for Alzheimer's disease
Apr 23, 2014
A study of older adults at increased risk for Alzheimer's disease shows that moderate physical activity may protect brain health and stave off shrinkage of the hippocampus– the brain region responsible ...
Recommended for you
Drug therapy halts clinical progression in Alzheimer patients
20 minutes ago
AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease ...
New amyloid-reducing compound could be a preventive measure against Alzheimer's
Jun 03, 2014
Scientists at NYU Langone Medical Center have identified a compound, called 2-PMAP, in animal studies that reduced by more than half levels of amyloid proteins in the brain associated with Alzheimer's disease. The researchers ...
Helping family caregivers cope with the daily stress of providing care to a relative with dementia
May 29, 2014
A Symposium on Dementia and Caregiving featuring leading US Dementia Expert, Professor Steve Zarit, an eminent clinician and academic, working in the field of ageing, dementia and caregiving for over 40 years took place in ...
Scientists find an unlikely stress responder may protect against Alzheimer's
May 21, 2014
In surprise findings, scientists at The Scripps Research Institute (TSRI) have discovered that a protein with a propensity to form harmful aggregates in the body when produced in the liver protects against ...
Compound reverses symptoms of Alzheimer's disease in mice, research shows
May 20, 2014
A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease, according to findings in the May issue of the ...
Cognitive test can differentiate between Alzheimer's and normal aging
May 20, 2014
Researchers have developed a new cognitive test that can better determine whether memory impairments are due to very mild Alzheimer's disease or the normal aging process.
User comments
© Medical Xpress 2011-2014, Science X network
by Bob Shepard
Neurologist David Geldmacher, M.D., who leads the University of Alabama at Birmingham memory disorders program, sees a lot of older patients with memory loss, dementia or Alzheimer's disease.
One of the questions frequently asked of him by the caregivers of these patients, often a spouse or the patients' adult children, is "could this happen to me?"
"It is very common for family members of a patient receiving a diagnosis of Alzheimer's disease or other form of dementia to wonder about their own risk," said Geldmacher, the director of the UAB Division of Memory Disorders and Behavioral Neurology.
Geldmacher is launching a new clinical effort—the first of its type in the United States—to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age. The assessment will include family history, a detailed memory history for the patient, cognitive testing and a baseline MRI scan. That information can be incorporated into existing risk predictor models that have been validated by research studies to produce an accurate risk assessment.
Patients will get a comprehensive analysis from Geldmacher, including information on nonmodifiable risk factors such as age and family history, as well as strategies for dealing with modifiable risk factors like weight, diet, blood pressure and level of physical activity. He says research in the field has shown that reducing one or more risk factors can have a significant effect on reducing one's overall chances of developing Alzheimer's disease.
"Our goal is to understand what risk factors are present in each individual and create a plan that best helps them reduce their risk and make appropriate plans for the future," Geldmacher said.
The assessment is targeted primarily at individuals in their 50s and 60s, and it will provide a 20-year risk prediction. It can also be used for individuals in later life, with a six-year risk prediction.
"For most people, Alzheimer's disease is an illness you live with, not an illness from which you die," Geldmacher said. "With a better understanding of individual risk, there are steps that people can take to minimize the risk for serious memory loss."
Patients will have two clinical visits with Geldmacher and his staff. The first will be to compile histories and conduct testing. The second will be to review a personalized treatment plan, including how to access resources to help achieve lifestyle changes, and where to find supportive and educational materials. The clinic will also suggest coping strategies that can be employed to ease the burden of dementia on the individual and his or her family. The two-visit assessment is fee-for-service and will cost about $1,000, which includes the MRI scan.
Geldmacher says this risk assessment service appears to be the first in the nation offered in a clinical setting and not as part of a research study.
"It's really for those who are worried about their cognitive health but do not currently have major memory issues," he said. "People with active memory or cognitive issues that interfere with everyday activities are best cared for through the services of our existing UAB Memory Disorders Clinic."
Geldmacher anticipates that the risk assessment clinic will also ultimately serve as a gateway to research projects aimed at finding medications or other treatments designed to lower risk of memory disorders.
Explore further: Early cardiac risks linked to worse cognitive function in middle age
More information: http://ift.tt/1kqHQ6Y
Medical Xpress on facebook
Related Stories
Early cardiac risks linked to worse cognitive function in middle age
Mar 31, 2014
Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UC San Francisco.
Making sense of genetic testing for heart disease
Apr 28, 2014
(Medical Xpress)—A new study by academics at The University of Nottingham looks at how patients respond to genetic testing for risk of coronary heart disease (CHD).
Policy changes urgently needed as millions to start receiving early label of Alzheimer's
Apr 08, 2014
How will we, as individuals, and a society, live with brains at risk for Alzheimer's disease dementia? As part of Health Affairs' April issue, a theme issue focusing on Alzheimer's, a neurodegenerative disease ethicist and cl ...
New study announced that will use genetics to test for Alzheimer's risk
Jul 19, 2012
In a new Alzheimer's disease risk assessment study unveiled this week during the Alzheimer's Association International Conference, researchers at Brigham and Women's Hospital (BWH) are offering genetic testing and Alzheimer's ...
Physical activity keeps hippocampus healthy in people at risk for Alzheimer's disease
Apr 23, 2014
A study of older adults at increased risk for Alzheimer's disease shows that moderate physical activity may protect brain health and stave off shrinkage of the hippocampus– the brain region responsible ...
Recommended for you
Drug therapy halts clinical progression in Alzheimer patients
20 minutes ago
AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease ...
New amyloid-reducing compound could be a preventive measure against Alzheimer's
Jun 03, 2014
Scientists at NYU Langone Medical Center have identified a compound, called 2-PMAP, in animal studies that reduced by more than half levels of amyloid proteins in the brain associated with Alzheimer's disease. The researchers ...
Helping family caregivers cope with the daily stress of providing care to a relative with dementia
May 29, 2014
A Symposium on Dementia and Caregiving featuring leading US Dementia Expert, Professor Steve Zarit, an eminent clinician and academic, working in the field of ageing, dementia and caregiving for over 40 years took place in ...
Scientists find an unlikely stress responder may protect against Alzheimer's
May 21, 2014
In surprise findings, scientists at The Scripps Research Institute (TSRI) have discovered that a protein with a propensity to form harmful aggregates in the body when produced in the liver protects against ...
Compound reverses symptoms of Alzheimer's disease in mice, research shows
May 20, 2014
A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease, according to findings in the May issue of the ...
Cognitive test can differentiate between Alzheimer's and normal aging
May 20, 2014
Researchers have developed a new cognitive test that can better determine whether memory impairments are due to very mild Alzheimer's disease or the normal aging process.
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment